These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 11035317

  • 1. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
    Hogg BB, Tamura T, Johnston KE, Dubard MB, Goldenberg RL.
    Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
    [Abstract] [Full Text] [Related]

  • 2. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I, Cozzi V, Pasqualini F, Nebuloni M, Garlanda C, Vago L, Pardi G, Mantovani A.
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [Abstract] [Full Text] [Related]

  • 3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E, Sifakis S, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E, Kalmanti M.
    Growth Horm IGF Res; 2006 May; 16(5-6):290-6. PubMed ID: 16996762
    [Abstract] [Full Text] [Related]

  • 4. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM, Wheeler T, Anthony F, Conroy R, O'herlihy C, McKenna P.
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [Abstract] [Full Text] [Related]

  • 5. [Increase of hemoglobin concentration in blood during the second trimester of pregnancy in relation to later pregnancy complications such as hypertension and intrauterine fetal growth inhibition].
    Jendryczko A, Tomala J.
    Wiad Lek; 1993 Mar; 46(5-6):201-5. PubMed ID: 8249398
    [Abstract] [Full Text] [Related]

  • 6. [Plasma homocysteine concentration and its relationship with the development of preeclampsia. Effect of prenatal administration of folic acid].
    Fernández M, Fernández G, Diez-Ewald M, Torres E, Vizcaíno G, Fernández N, Narváez J, Arteaga-Vizcaíno M.
    Invest Clin; 2005 Jun; 46(2):187-95. PubMed ID: 16001750
    [Abstract] [Full Text] [Related]

  • 7. Plasma volume determination in pregnancies complicated by chronic hypertension and intrauterine fetal demise.
    Sibai BM, Abdella TN, Anderson GD, McCubbin JH.
    Obstet Gynecol; 1982 Aug; 60(2):174-8. PubMed ID: 7155477
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction.
    Sabatier F, Bretelle F, D'ercole C, Boubli L, Sampol J, Dignat-George F.
    Am J Obstet Gynecol; 2000 Dec; 183(6):1558-63. PubMed ID: 11120528
    [Abstract] [Full Text] [Related]

  • 9. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
    Chammas MF, Nguyen TM, Li MA, Nuwayhid BS, Castro LC.
    Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
    [Abstract] [Full Text] [Related]

  • 10. Serum homocysteine level and its association with folic acid and vitamin B12 in the third trimester of pregnancies complicated with intrauterine growth restriction.
    Gadhok AK, Sinha M, Khunteta R, Vardey SK, Upadhyaya C, Sharma TK, Jha M.
    Clin Lab; 2011 Oct; 57(11-12):933-8. PubMed ID: 22239024
    [Abstract] [Full Text] [Related]

  • 11. Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia.
    Yu CK, Lakasing L, Papageorghiou AT, Spencer K, Nicolaides KH.
    J Matern Fetal Neonatal Med; 2004 Aug; 16(2):134-9. PubMed ID: 15512726
    [Abstract] [Full Text] [Related]

  • 12. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia.
    Makedos G, Papanicolaou A, Hitoglou A, Kalogiannidis I, Makedos A, Vrazioti V, Goutzioulis M.
    Arch Gynecol Obstet; 2007 Feb; 275(2):121-4. PubMed ID: 16941105
    [Abstract] [Full Text] [Related]

  • 13. Correlation between maternal plasma homocysteine and zinc levels in preeclamptic women.
    Harma M, Harma M, Kocyigit A.
    Biol Trace Elem Res; 2005 May; 104(2):97-105. PubMed ID: 15894810
    [Abstract] [Full Text] [Related]

  • 14. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
    Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW.
    Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
    [Abstract] [Full Text] [Related]

  • 15. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, Cuckle H, Wolf M.
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [Abstract] [Full Text] [Related]

  • 16. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH, Chen SF, Lo LM, Li MJ, Yeh YL, Hsieh TT.
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [Abstract] [Full Text] [Related]

  • 17. Changes of plasma fibronectin levels in pregnancy induced hypertension.
    Paneva-Masin J, Zafirovska K, Bogdanovska S, Lozance L, Gerasimovska B.
    Acta Med Croatica; 2000 Apr; 54(4-5):157-60. PubMed ID: 11379479
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia.
    Cotter AM, Molloy AM, Scott JM, Daly SF.
    Am J Obstet Gynecol; 2001 Oct; 185(4):781-5. PubMed ID: 11641651
    [Abstract] [Full Text] [Related]

  • 19. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
    Ong CY, Liao AW, Munim S, Spencer K, Nicolaides KH.
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
    [Abstract] [Full Text] [Related]

  • 20. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
    Savvidou MD, Sotiriadis A, Kaihura C, Nicolaides KH, Sattar N.
    Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.